International Stem Cell board backs USD 25 million sale of Lifeline Cell Technology to ATCC
Reuters2026/08/04 21:12- International Stem Cell’s board, acting by unanimous written consent on July 10, 2026, cleared a sale of its Lifeline Cell Technology unit.
- Transaction calls for selling 100% of Lifeline Cell Technology membership interests to ATCC for USD 25 million, subject to working-capital, cash, debt adjustments.
- ATCC to pay cash at closing, withholding USD 2.5 million for an indemnity escrow, USD 100,000 for an adjustment escrow.
- Board also authorized execution of the purchase agreement and related documents, submitting the deal for stockholder approval by written consent.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Colgate-Palmolive (CL.US) plans to sell part of its personal care brands, with a total transaction amount possibly exceeding 1.1 billions USD.
According to sources familiar with the matter, Colgate is exploring the sale of some of its mass-market personal care brands. The company currently plans to divest only a few brands within its personal care business, and the combined sale price may exceed 1 billion dollars.
EdiliziAcrobatica announces shareholder meeting notice
Storage Giant Offers Huge Bonuses Again: Micron Awards Up to 68 Months’ Bonus
Micron Technology has announced record-breaking bonuses for its employees in Taiwan, ranging from 35 to 68 months’ salary, with a minimum cash compensation of 1.7 million New Taiwan dollars. However, the Taoyuan union, representing about two-thirds of Micron’s workers in Taiwan, has refused to accept the offer, insisting that 15% of operating profits be included in the bonus distribution and maintaining the threat of a strike.
Crypto prices
More
